Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBL.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.56NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.56NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.56NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.1.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.1.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.5.49NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.5.49NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.5.49NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBL.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBL.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBL.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FL.17NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FL.17NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FL.17NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.2.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.2.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
GK.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GK.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GK.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XCMNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XCMNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XCMNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HN.5NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HN.5NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.5NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.42.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.42.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.42.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HN.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HN.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HN.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
DV.7.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
DV.7.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
DV.7.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.20.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
HK.20.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
HK.20.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
FY.5.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
FY.5.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FY.5.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
HK.13.2.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used